Success Metrics

Clinical Success Rate
87.1%

Based on 659 completed trials

Completion Rate
87%(659/757)
Active Trials
109(10%)
Results Posted
37%(247 trials)
Terminated
98(9%)

Phase Distribution

Ph early_phase_1
39
3%
Ph phase_1
172
15%
Ph phase_3
115
10%
Ph phase_4
292
25%
Ph phase_2
189
16%
Ph not_applicable
337
29%

Phase Distribution

211

Early Stage

189

Mid Stage

407

Late Stage

Phase Distribution1144 total trials
Early Phase 1First-in-human
39(3.4%)
Phase 1Safety & dosage
172(15.0%)
Phase 2Efficacy & side effects
189(16.5%)
Phase 3Large-scale testing
115(10.1%)
Phase 4Post-market surveillance
292(25.5%)
N/ANon-phased studies
337(29.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.5%

659 of 819 finished

Non-Completion Rate

19.5%

160 ended early

Currently Active

109

trials recruiting

Total Trials

1,147

all time

Status Distribution
Active(148)
Completed(659)
Terminated(160)
Other(180)

Detailed Status

Completed659
unknown174
Terminated98
Recruiting84
Withdrawn62
Not yet recruiting31

Development Timeline

Analytics

Development Status

Total Trials
1147
Active
109
Success Rate
87.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 139 (3.4%)
Phase 1172 (15.0%)
Phase 2189 (16.5%)
Phase 3115 (10.1%)
Phase 4292 (25.5%)
N/A337 (29.5%)

Trials by Status

active_not_recruiting252%
unknown17415%
not_yet_recruiting313%
enrolling_by_invitation81%
terminated989%
completed65957%
recruiting847%
withdrawn625%
suspended61%

Recent Activity

Clinical Trials (1,147)

Showing 20 of 1,147 trialsScroll for more
NCT06726577Phase 1

TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis

Recruiting
NCT07361549Phase 2

Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment

Recruiting
NCT06376916Phase 3

Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

Recruiting
NCT06251635Not Applicable

Effects of Antipsychotics on Brain Insulin Action in Females

Active Not Recruiting
NCT06143059Phase 3

The Effects of Sex Hormones and Alcohol on Sleep

Suspended
NCT07796178Phase 4

Evaluation of Lacrifill

Recruiting
NCT07703514Phase 1

Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates

Not Yet Recruiting
NCT05301192Early Phase 1

Angiotensin-(1-7) Cardiovascular Effects in Aging

Terminated
NCT03777215Early Phase 1

Angiotensin-(1-7) and Energy Expenditure in Human Obesity

Completed
NCT06482853Early Phase 1

Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension

Recruiting
NCT02392442Phase 2

Effects of Bronchial Segmental Endotoxin Instillation in Humans

Enrolling By Invitation
NCT04600089Phase 2

Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI

Completed
NCT07230496Phase 1

A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healthy Overweight/Obese Participants

Recruiting
NCT05323149Phase 3

Dexamethasone in Traumatic Brain Injury

Recruiting
NCT01988545Not Applicable

GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow

Completed
NCT06480201Phase 1

Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

Recruiting
NCT02134925Phase 2

Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps

Active Not Recruiting
NCT07622355Phase 1

Effects of Different Administration Routes of Dexmedetomidine on Postoperative Sleep Quality in Patients Undergoing Thyroidectomy

Completed
NCT05979493Phase 4

QL Block in Laparoscopic Myomectomy

Recruiting
NCT07131033Not Applicable

Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholecystectomy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
1,147